Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Membranous Glomerulonephritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04154787
What this trial is testing

Efficacy and Safety of LNP023 Compared With Rituximab in Subjects With Idiopathic Membranous Nephropathy

Who this might be right for
Idiopathic Membranous Nephropathy
Novartis Pharmaceuticals 37
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07730632
What this trial is testing

Phase II Clinical Study on the Efficacy and Safety of QLS7305 in Patients With Kidney Disease (Part A)

Who this might be right for
IgAN - IgA NephropathyImmune Complex Membranoproliferative Glomerulonephritis (IC-MPGN)C3 Glomerulopathy (C3G)+1 more
Qilu Pharmaceutical Co., Ltd. 60
Testing effectiveness (Phase 2)Looking for participantsNCT07157787
What this trial is testing

Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)

Who this might be right for
Primary Membranous Nephropathy
Alexion Pharmaceuticals, Inc. 30
Large-scale testing (Phase 3)Study completedNCT00135954
What this trial is testing

Treatment of Patients With Idiopathic Membranous Nephropathy

Who this might be right for
Glomerulonephritis, Membranous
Radboud University Medical Center 29
Not applicableUnknownNCT02610595
What this trial is testing

Study on the Therapeutic Effect of TCM Treatment for MDR MN

Who this might be right for
Idiopathic Membranous Nephropathy
Shanghai University of Traditional Chinese Medicine 220
Very early researchLooking for participantsNCT07203404
What this trial is testing

Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases.

Who this might be right for
SLELNANCA Associated Vasculitis+6 more
Nanjing Bioheng Biotech Co., Ltd. 96
Post-approval studies (Phase 4)Looking for participantsNCT05839314
What this trial is testing

Effect of Huaier Granule on the Treatment of Idiopathic Membranous Nephropathy

Who this might be right for
NephropathyGlomerular DiseasesIdiopathic Membranous Nephropathy
Chinese PLA General Hospital 480
Not applicableUnknownNCT05688865
What this trial is testing

Correlation and Clinical Utility of Urinary Biomarker in Membranous Glomerulonephritis

Who this might be right for
Membranous Nephropathy
Chinese University of Hong Kong 50
Testing effectiveness (Phase 2)Looking for participantsNCT04456816
What this trial is testing

The Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With AP1189 in Patients With iMN and Severe Proteinuria

Who this might be right for
Nephrotic Syndrome Due to Idiopathic Membranous NephropathySevere Proteinuria Due to Idiopathic Membranous Nephropathy
SynAct Pharma Aps 23
Large-scale testing (Phase 3)UnknownNCT03018535
What this trial is testing

Rituximab Versus Steroids and Cyclophosphamide in the Treatment of Idiopathic Membranous Nephropathy

Who this might be right for
Glomerulonephritis, Membranous
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 76
Post-approval studies (Phase 4)Study completedNCT00843856
What this trial is testing

Mycophenolate Mofetil and Tacrolimus Versus Tacrolimus for the Treatment of Idiopathic Membranous Glomerulonephritis

Who this might be right for
Glomerulonephritis, Membranous
Imperial College Healthcare NHS Trust 40
Large-scale testing (Phase 3)Study completedNCT00425217
What this trial is testing

Rituximab in Membranous Nephropathy

Who this might be right for
Membranous Nephropathy
Mayo Clinic 15
Large-scale testing (Phase 3)Study completedNCT00404794
What this trial is testing

Compare Mycophenolate Mofetil and Tacrolimus in the Treatment of Membranous Lupus Nephritis

Who this might be right for
Lupus NephritisGlomerulonephritis, Membranous
Hospital Authority, Hong Kong 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05732402
What this trial is testing

An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases

Who this might be right for
Lupus NephritisImmunoglobulin A NephropathyMembranous Nephropathy+1 more
Alpine Immune Sciences, Inc. 72
Not applicableStudy completedNCT03255447
What this trial is testing

Peptide GAM Immunoadsorption Therapy in Autoimmune Membranous Nephropathy

Who this might be right for
Autoimmune Membranous Nephropathy
Manchester University NHS Foundation Trust 12
Testing effectiveness (Phase 2)Looking for participantsNCT07096843
What this trial is testing

Budoprutug in Subjects With Primary Membranous Nephropathy

Who this might be right for
Primary Membranous Nephropathy
Climb Bio, Inc. 45
Early research (Phase 1)Not Yet RecruitingNCT07234474
What this trial is testing

A Phase I Study of YK012 in Primary Membranous Nephropathy

Who this might be right for
Primary Membranous Nephropathy
Excyte Biopharma Ltd 66
Not applicableStudy completedNCT05428605
What this trial is testing

In Vitro Immunomodulation in Membranous Nephropathy Relapses

Who this might be right for
Extramembranous Glomerulopathy
Centre Hospitalier Universitaire de Nice 20
Testing effectiveness (Phase 2)Looking for participantsNCT07038382
What this trial is testing

Evaluate the Efficacy, Safety, and Tolerability of Human Sialidase Fusion Protein (HLX79) in Combination With Rituximab Injection Versus Placebo in Patients With Active Glomerulonephritis

Who this might be right for
Membranous NephropathyLupus Nephritis (LN)
Shanghai Henlius Biotech 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07765537
What this trial is testing

A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety and Efficacy of FKC289 in Subjects With Relapsed/Refractory Membranous Nephropathy

Who this might be right for
Primary Membranous Nephropathy
Shenzhen Fosun Kairos Biotechnology Co., Ltd. 55
Next Page